POS1177 TREATMENT WITH LORECIVIVINT LEADS TO IMPROVED LONG-TERM PATIENT ACCEPTABLE SYMPTOM STATE (PASS) COMPARED TO PLACEBO: DATA FROM PHASE 3 EXTENSION TRIAL - Swearingen, C.; Yazici, Y.; Tambiah, J. R. S.; Conaghan, P. G. (Annals of the rheumatic diseases, 2024)
Keywords: Clinical outcomes; Clinical Trial; Clinical trials; Inflammation; Injection; Knee; Osteoarthritis; Outcome measures; Pain; Patient Reported Outcome Measures; Patients; Placebos; Randomized controlled trial; Scientific Abstracts; Wnt protein